首页>
外国专利>
Nanoveso™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases
Nanoveso™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases
展开▼
机译:Nanoveso™:肝病和合并症的治疗,生物标志物和诊断测试
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method of treatment of liver diseases and comorbid diseases is disclosed wherein an oral dose of lipids in an amount effective to trigger the release of cholecystokinin (CCK) into the duodenum to generate a major release of bile phospholipids from remodeled stores of triglycerides (TAG) in the liver, is administered to a patient in need thereof, thereby causing the formation of sequestered and aggregated mixed micelles and vesicles (SAMMVs) in the intestines of the patient which are then eliminated via the bowels of the patient.
展开▼